[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 116 Introduced in Senate (IS)]

<DOC>






117th CONGRESS
  1st Session
                                 S. 116

 To require the Consumer Product Safety Commission to study the effect 
    of the COVID-19 pandemic on injuries and deaths associated with 
               consumer products, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            January 28, 2021

  Ms. Klobuchar (for herself and Mr. Moran) introduced the following 
 bill; which was read twice and referred to the Committee on Commerce, 
                      Science, and Transportation

_______________________________________________________________________

                                 A BILL


 
 To require the Consumer Product Safety Commission to study the effect 
    of the COVID-19 pandemic on injuries and deaths associated with 
               consumer products, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``COVID-19 Home Safety Act of 2021''.

SEC. 2. REPORT.

    (a) COVID-19 Report Required.--Not later than 3 months after the 
date of the enactment of this section and every 3 months thereafter for 
the duration of the COVID-19 public health emergency, the Consumer 
Product Safety Commission shall submit to the Committee on Energy and 
Commerce of the House of Representatives and the Committee on Commerce, 
Science, and Transportation of the Senate, and make publicly available, 
a report on the effect of the COVID-19 public health emergency on 
injuries and deaths from consumer products.
    (b) Contents of Report.--The report shall include the following:
            (1) A list of the top consumer products, prioritizing 
        products that have been associated with the highest risk of 
        serious injury or death during the COVID-19 emergency. The list 
        under this paragraph should be based on relevant data and 
        statistics from--
                    (A) the data sources of the Commission;
                    (B) other appropriate agencies;
                    (C) media reports;
                    (D) poison control centers, to the extent 
                practical; and
                    (E) any other relevant data sources.
            (2) An identification of trends in injuries and deaths in 
        the consumer products listed under paragraph (1), comparing 
        data from representative time periods before and during the 
        COVID-19 public health emergency.
            (3) An identification of subpopulations that have 
        experienced elevated risk of injury or death from the consumer 
        products listed under paragraph (1) during the COVID-19 public 
        health emergency, such as minorities, infants, people with 
        disabilities, children, or the elderly.
            (4) An identification of where most injuries or deaths from 
        consumer products during the COVID-19 public health emergency 
        are taking place, such as the type of building or outdoor 
        environment.
            (5) An identification of whether any specific consumer 
        products in the categories described in paragraph (1) are--
                    (A) under recall or other corrective action;
                    (B) subject to a voluntary consumer product safety 
                standard; or
                    (C) subject to a mandatory consumer product safety 
                standard.
            (6) An identification of any emerging consumer products or 
        consumer product categories that are posing new risks to 
        consumers.
            (7) A comprehensive assessment of the Commission's 
        operations, re-entry criteria and associated metrics, 
        operational readiness, enforcement efforts (including import-
        export surveillance of counterfeit and untested consumer goods 
        and laboratory functions), and corrective action taken 
        (including the number of corrective actions announced and 
        recall effectiveness) during the COVID-19 public health 
        emergency and recommendations to improve the Commission's 
        ability to address unforeseen effects of the COVID-19 public 
        health emergency with regard to consumer product safety.
    (c) Distribution of Information.--The Consumer Product Safety 
Commission shall coordinate with public media outlets to distribute 
resource information based on the report under this section to help 
increase home safety during the COVID-19 public health emergency, 
including information such as Home Safe Checklists.
    (d) COVID-19 Public Health Emergency Defined.--The term ``COVID-19 
public health emergency'' means a public health emergency declared 
pursuant to section 319 of the Public Health Service Act (42 U.S.C. 
247d) as a result of confirmed cases of 2019 novel coronavirus (COVID-
19), including any renewal thereof.
                                 <all>